Managing Tariff Impacts
As global economic conditions continue to evolve, we remain steadfast in our mission to provide high-quality, affordable, and reliable medicines and medical technologies to the caregivers and patients who depend on us. Recently, fluctuating tariff conditions in the United States have created new challenges across industries, and we want to assure you that we are actively managing this situation.
What We're Doing to Manage Tariff Impacts
Commitment to Local-for-Local Manufacturing
Our global manufacturing strategy is built around a local-for-local approach, emphasizing supply chain resilience and responsiveness. We produce 70% of the medicine we sell in the U.S. domestically and source high-value active ingredients locally when possible. We’ve invested nearly $1 billion in U.S. manufacturing and logistics in recent years, a commitment that differentiates us from many others.
Immediate Mitigation Measures
To minimize immediate impacts, we have increased inventories of key materials sourced internationally and diversified our supplier network to ensure continuity of supply. These efforts are designed to reduce the risk of disruption while maintaining product availability.
Introducing Our Pledge to Customers
We recognize that our customers—including hospitals, clinics and blood centers—are also under financial pressure. As we navigate this environment, we are proud to introduce our Pledge to Customers, which reaffirms our commitment to transparency, ethical practices and responsible decision-making.
Potential Impact on Product Pricing
While we are taking every possible measure to mitigate the effects of tariffs, some adjustments to product pricing may be necessary. If price changes become unavoidable, we are committed to communicating these changes openly and transparently.
We appreciate the trust you place in us and are committed to delivering value, reliability and quality. Thank you for your understanding and support.
